BioSpace News Archive

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), the science-focused, multi-state cannabis company headquartered in Minneapolis, today announced that John Heller has been appointed as Chief Financial Officer (“CFO”), effective July 6, 2020.

Emmaus Life Sciences, Inc. (OTCQB: EMMA) , a leader in sickle cell disease treatment, announced today that it was issued a license from the Israeli Ministry of Health on June 17, 2020 granting marketing authorization for the commercial distribution and sale of Endari® in Israel. Endari® is approved in Israel as in the U.S. as an amino acid indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients

Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the Russell 2000 ® and the Russell 3000 ® indexes following the annual reconstitution, effective after the U.S. market opens today, June 29, 2020. Annual Russell indexes reconstitution captures the 4,000 largest U.S. stocks as of May 8, r